Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center

被引：3
|
作者：
Dennehy, Colum
Mullally, Will
Goggin, Caitriona
Gleeson, Jack Patrick
Greene, John Patrick
Power, Derek Gerard
O'Reilly, Seamus
Collins, Dearbhaile Catherine
O'Mahony, Deirdre
Bambury, Richard Martin
机构：
[1] Cork Univ Hosp, Cork, Ireland
[2] MMUH, Dublin, Ireland
[3] Adelaide & Meath Hosp, Dublin, Ireland
[4] Mercy Univ Hosp, Cork, Ireland
[5] Inst Canc Res, Sutton, Surrey, England
[6] Royal Marsden Hosp, Sutton, Surrey, England
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[8] Weill Cornell Med Coll, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21196
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21196
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience
    Monaco, Lavinia
    Gemelli, Maria
    Gotuzzo, Irene
    Bauckneht, Matteo
    Crivellaro, Cinzia
    Genova, Carlo
    Cortinovis, Diego
    Zullo, Lodovica
    Ammoni, Luca Carlofrancesco
    Bernasconi, Davide Paolo
    Rossi, Giovanni
    Morbelli, Silvia
    Guerra, Luca
    CANCERS, 2021, 13 (07)
  • [42] The safety and efficacy of pembrolizumab for the treatment of non-small cell lung cancer
    Mazarico Gallego, Jose Ma
    Herrera Juarez, Mercedes
    Paz-Ares, Luis
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 233 - 242
  • [43] Long-Lasting Therapeutic Response following Treatment with Pembrolizumab in Patients with Non-Small Cell Lung Cancer: A Real-World Experience
    Shalata, Walid
    Zolnoorian, Jeremy
    Migliozzi, Gabrielle
    Jama, Ashraf Abu
    Dudnik, Yulia
    Cohen, Ahron Yehonatan
    Meirovitz, Amichay
    Yakobson, Alexander
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [44] Advances in the Treatment of Non–small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab
    Konstantinos Leventakos
    Aaron S. Mansfield
    BioDrugs, 2016, 30 : 397 - 405
  • [45] The safety of nivolumab for the treatment of advanced non-small cell lung cancer
    Metro, Giulio
    Ricciuti, Biagio
    Brambilla, Marta
    Baglivo, Sara
    Soli, Irene
    Minenza, Elisa
    Leonardi, Giulia Costanza
    D'arpino, Alessandro
    Colabrese, Daniela
    Tazza, Marco
    Zicari, Daniela
    Minotti, Vincenzo
    Chiari, Rita
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (01) : 101 - 109
  • [46] The role of pembrolizumab in the treatment of advanced non-small cell lung cancer
    Santabarbara, Giuseppe
    Maione, Paolo
    Rossi, Antonio
    Palazzolo, Giovanni
    Gridelli, Cesare
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)
  • [47] Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab
    Freeman, A. T.
    Lesperance, M.
    Wai, E. S.
    Croteau, N. S.
    Fiorino, L.
    Geller, G.
    Brooks, E. G.
    Poonja, Z.
    Fenton, D.
    Irons, S.
    Ksienski, D.
    CURRENT ONCOLOGY, 2020, 27 (02) : 76 - 82
  • [48] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [49] Pembrolizumab in Metastatic Non-Small Cell Lung Cancer (NSCLC): Real World Data of Patient Outcomes from a District General Hospital
    Roberts, Christopher
    Hesford, James
    Lewis, Pippa
    Tillett, Tania
    Cox, R. Ashley
    LUNG CANCER, 2024, 190
  • [50] Economic aspects of nivolumab in non-small cell lung cancer (NSCLC): Lessons from real life.
    Dudnik, Elizabeth
    Roisman, Laila
    Bar, Jair
    Peled, Nir
    Hammerman, Ariel
    Daher, Sameh
    Moskovitz, Mor Tal
    Shama, Sivan
    Hanovich, Ekaterina
    Zer, Alona
    Merimsky, Ofer
    Wollner, Mira
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345